Neither stratifying the analysis by clinical stage nor based on APOE4 status and KL-VS heterozygosity status showed a significant difference in the associations between CSF Klotho levels and levels of any of the 3 AD CSF biomarkers (eTables 1 and 2 in the Supplement). This evidence concerns the gene KL and Alzheimer disease.